Latest Breaking News On - Advanced immunomodulating multi receptor system - Page 1 : comparemela.com

Share this article Share this article FORT COLLINS, Colo., April 20, 2021 /PRNewswire/  Cytocom, Inc. (Cytocom), a leading biopharmaceutical company creating next generation immune therapies built around proprietary discovery and development technologies, today announced that Stephen Wilson, Ph.D., has joined the company as its Head of Global Innovations, effective April 19, 2021. Dr. Wilson arrives at Cytocom after spending nearly 25 years at the La Jolla Institute for Immunology (LJII) where he was active in biomedical research and served as the research facility s chief operating officer. As Head of Global Innovation for Cytocom, Dr. Wilson will help identify new indications for Cytocom s existing pipeline of assets designed to rebalance the body s immune system and restore homeostasis and lead efforts to develop a global network of researchers and scientists to collaborate with Cytocom in new applications for its AIMS™ (Advanced Immunomodulating Multi-Receptor System) dr

Johanna bennettMaureen mcenroeMike handleyCleveland biolabsStephen wilsonImquest life sciencesInvivoscribe technologies incJolla institute for immunologyCytocom incUniversity of arizona college medicineGlobal innovationsGlobal innovationAdvanced immunomodulating multi receptor systemChief executive officerImquest lifeExecutive vice president